WEST PHARMACEUTICAL SERVICES INC

WST

WEST PHARMACEUTICAL SERVICES INC

WST

Insider Sentiment (TTM):

Last Purchase:-Last Sale:2026-04-27Shares Purchased (TTM):0Shares Sold (TTM):3,713

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:65,416,263Shares Outstanding:72,000,000Institutional Ownership Pct.:90.86%

Earnings Market Reaction:

Filing Date:2026-07-23Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	436	521	791	629	510	404	485	491	446	602	854	899
Accounts Receivable Net Current	712	686	574	625	582	544	553	524	479	524	512	519
Inventory Net	447	453	444	438	421	389	377	401	419	430	435	432
Other Assets Current	212	167	169	132	168	121	124	134	138	137	136	123
Assets Current	1,808	1,827	1,978	1,823	1,681	1,458	1,538	1,551	1,483	1,693	1,936	1,972
Property Plant And Equipment Gross	3,249	3,223	3,223	3,233	3,178	3,005	2,986	2,991	2,864	2,791	2,738	2,607
Accumulated Depreciation Depletion And Amortizatio…	1,562	1,521	1,497	1,492	1,456	1,374	1,404	1,420	1,370	1,343	1,325	1,296
Property Plant And Equipment Net	1,686	1,702	1,726	1,741	1,722	1,632	1,582	1,571	1,494	1,449	1,413	1,312
Operating Lease Right Of Use Asset	105	110	117	98	104	103	105	108	110	97	99	97
Investments In Affiliates Subsidiaries Associates …	208	209	212	221	225	212	202	218	198	203	210	195
Goodwill	109	109	110	111	111	108	106	109	107	108	109	107
Intangible Assets Net Excluding Goodwill	6	7	8	9	10	10	11	12	13	14	15	16
Deferred Income Tax Assets Net	72	64	38	28	30	26	26	38	34	21	26	17
Other Assets Noncurrent	83	81	80	76	71	70	74	69	50	19	21	39
Assets	4,076	4,110	4,270	4,106	3,953	3,618	3,643	3,675	3,489	3,602	3,830	3,755
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	253	252	254	256	239	228	239	224	212	240	242	220
Accrued Income Taxes Current	65	79	28	33	29	22	32	33	17	17	17	15
Operating Lease Liability Current	21	21	23	21	21	22	18	20	20	18	18	17
Accrued Liabilities Current	34	47	-	-	-	-	-	-	-	-	-	-
Other Liabilities Current	171	202	215	213	223	186	188	159	169	174	155	137
Liabilities Current	641	674	655	635	605	527	550	517	634	648	672	534
Long Term Debt Noncurrent	203	203	203	203	203	203	203	203	73	73	73	152
Deferred Income Tax Liabilities Net	22	23	23	23	23	21	21	9	14	13	13	17
Pension And Other Postretirement Defined Benefit P…	28	29	29	31	31	29	28	30	29	29	30	28
Operating Lease Liability Noncurrent	88	92	96	74	80	79	82	82	85	82	85	83
Deferred Compensation Liability Classified Noncurr…	14	12	14	14	13	11	15	15	16	19	19	18
Other Liabilities Noncurrent	90	88	75	75	70	66	62	67	63	58	59	55
Liabilities	1,086	1,119	1,094	1,054	1,024	935	961	923	913	922	949	887
Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	19	19	19	19	19	19	19	19	19	19	19	19
Additional Paid In Capital	0	0	0	0	0	2	22	23	34	55	120	123
Retained Earnings Accumulated Deficit	4,624	4,476	4,375	4,262	4,139	4,031	3,957	3,857	3,721	3,624	3,523	3,416
Accumulated Other Comprehensive Income Loss Net Of…	-140	-125	-106	-102	-89	-206	-258	-136	-217	-192	-144	-223
Treasury Stock Common Value	-1,512	-1,379	-1,112	-1,127	-1,140	-1,163	-1,057	-1,011	-980	-825	-638	-466
Stockholders Equity	2,990	2,990	3,176	3,052	2,929	2,683	2,682	2,752	2,577	2,681	2,881	2,868
Liabilities And Stockholders Equity	4,076	4,110	4,270	4,106	3,953	3,618	3,643	3,675	3,489	3,602	3,830	3,755
Preferred Stock Shares Authorized	3	3	3	3	3	3	3	3	3	3	3	3
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.25	0.25	0.25	0.25	0.25	0.25	0.25	0.25	0.25	0.25	0.25	0.25
Common Stock Shares Authorized	200	200	200	200	200	200	200	200	200	200	200	200
Common Stock Shares Issued	75	75	75	75	75	75	75	75	75	75	75	75
Shares Outstanding	70	71	72	72	72	72	72	73	73	73	74	74
Treasury Stock Common Shares	5	4	3	3	3	4	3	3	3	2	2	1

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-2.13%	6.25%	14.30%	-	-	-	-	-	-	-	-	-
2025	2.97%	5.48%	7.98%	-11.71%	-9.10%	-6.13%	-14.87%	-12.85%	-10.26%	-3.18%	5.49%	34.12%
2024	-3.41%	-9.49%	-12.28%	8.46%	8.55%	6.48%	-4.83%	-0.12%	0.39%	9.06%	-0.14%	1.08%
2023	-	-	-	9.26%	11.07%	8.50%	4.78%	9.50%	6.01%	10.69%	8.52%	4.06%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	2.82	2.71	3.02	2.87	2.78	2.77	2.79	3.00	2.34	2.61	2.88	3.70
Quick Ratio	2.12	2.04	2.34	2.18	2.08	2.03	2.11	2.23	1.68	1.95	2.24	2.89
Working Capital	1.17B	1.15B	1.32B	1.19B	1.08B	930.80M	987.70M	1.03B	849.30M	1.04B	1.26B	1.44B
Leverage & Debt
Debt to Equity	0.36	0.37	0.34	0.35	0.35	0.35	0.36	0.34	0.35	0.34	0.33	0.31
Interest Coverage TTM	138.86	272.92	649.89	391.93	290.80	162.97	123.89	114.24	81.56	76.61	75.11	67.87
Debt Ratio	0.27	0.27	0.26	0.26	0.26	0.26	0.26	0.25	0.26	0.26	0.25	0.24
Efficiency & Turnover
Asset Turnover TTM	0.83	0.83	0.78	0.78	0.80	0.80	0.77	0.77	0.80	0.80	0.79	0.83
Days Sales Outstanding TTM	71.01	69.65	66.90	69.50	65.46	67.28	67.15	66.20	64.31	64.65	63.07	62.64
Receivables Turnover TTM	5.14	5.24	5.46	5.25	5.58	5.42	5.44	5.51	5.68	5.65	5.79	5.83
Per Share Metrics
Diluted EPS TTM	7.92	7.50	6.79	6.77	6.73	6.40	6.69	6.81	7.12	7.65	7.88	7.43
Free Cash Flow Per Share TTM	6.17	6.36	6.49	5.25	4.76	4.23	3.79	4.42	4.89	5.25	5.58	5.65
Dividend Per Share TTM	0.88	0.86	0.85	0.84	0.83	0.82	0.81	0.80	0.80	0.78	0.77	0.76
Margin Metrics
Gross Profit Margin TTM	36.79%	36.28%	35.91%	35.58%	35.27%	34.54%	34.51%	34.87%	35.69%	37.15%	38.28%	38.04%
Operating Profit Margin TTM	20.45%	20.34%	19.03%	19.48%	19.65%	19.13%	19.70%	19.86%	20.41%	21.97%	22.92%	22.03%
Net Profit Margin TTM	16.98%	16.85%	16.06%	16.29%	16.48%	16.13%	17.03%	17.37%	18.25%	19.42%	20.12%	19.11%
Growth Metrics
Net Revenue Growth (1Y)	12.38%	11.23%	6.25%	4.92%	2.90%	-1.12%	-1.92%	-1.71%	0.38%	1.56%	2.18%	0.60%
Net Income Growth (1Y)	15.83%	16.16%	0.20%	-1.58%	-7.09%	-17.85%	-16.97%	-10.69%	1.20%	3.01%	1.28%	-11.29%
EPS Growth (1Y)	18.12%	16.97%	1.17%	-0.76%	-6.06%	-16.71%	-15.49%	-8.85%	3.00%	4.41%	1.42%	-11.17%
Valuation Metrics
P/E TTM	44.96	33.21	40.20	38.40	32.26	34.57	48.26	43.47	45.50	50.76	43.74	49.41
P/B TTM	8.49	6.03	6.25	6.19	5.37	6.02	8.87	7.89	9.27	10.77	9.01	9.64
P/S TTM	7.64	5.59	6.46	6.26	5.32	5.58	8.22	7.55	8.30	9.86	8.80	9.45
Market Cap	25.40B	18.02B	19.85B	18.88B	15.74B	16.15B	23.78B	21.72B	23.88B	28.87B	25.96B	27.64B
Enterprise Value	25.17B	17.70B	19.26B	18.46B	15.43B	15.95B	23.50B	21.43B	23.51B	28.34B	25.17B	26.89B
Calculated Values
Free Cash Flow TTM	436.90M	458.00M	468.90M	379.10M	344.00M	306.90M	276.40M	321.60M	357.10M	386.10M	414.50M	420.00M
Net Debt	-232.90M	-318.60M	-588.50M	-425.80M	-307.10M	-201.60M	-282.00M	-288.30M	-373.30M	-529.00M	-781.10M	-746.50M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-04-27Sale

Owner: Favorite, Annette F

Title: Sr. VP & Chief HR Officer

Shares: 2,817

Price/Share: $305.20

Value: $859,748.40

Shares Owned: 16,828

Relationship: Officer

Ownership: Direct

2026-04-27Sale

Owner: Winters, Chad

Title: VP, Chief Accounting Officer

Shares: 896

Price/Share: $300.67

Value: $269,400.32

Shares Owned: 1,523

Relationship: Officer

Ownership: Direct

2024-10-29Sale

Owner: Witherspoon, Charles

Title: VP & Treasurer

Shares: 703

Price/Share: $310.40

Value: $218,211.20

Shares Owned: 1,253

Relationship: Officer

Ownership: Direct

2024-08-19Sale

Owner: Witherspoon, Charles

Title: VP & Treasurer

Shares: 1,029

Price/Share: $300.00

Value: $308,700.00

Shares Owned: 1,478

Relationship: Officer

Ownership: Direct

2024-08-06Sale

Owner: Green, Eric Mark

Title: President, CEO and Board Chair

Shares: 30,732

Price/Share: $304.71

Value: $9,364,347.72

Shares Owned: 161,898

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-04-27	Favorite, Annette F	Officer	Sr. VP & Chief HR Officer	Direct	Sale	2,817	305.20	$859,748.40	16,828	4
2026-04-27	Winters, Chad	Officer	VP, Chief Accounting Officer	Direct	Sale	896	300.67	$269,400.32	1,523	4
2024-10-29	Witherspoon, Charles	Officer	VP & Treasurer	Direct	Sale	703	310.40	$218,211.20	1,253	4
2024-08-19	Witherspoon, Charles	Officer	VP & Treasurer	Direct	Sale	1,029	300.00	$308,700.00	1,478	4
2024-08-06	Green, Eric Mark	Director,Officer	President, CEO and Board Chair	Direct	Sale	30,732	304.71	$9,364,347.72	161,898	4
2024-06-12	Abraham, Silji	Officer	SVP, Chief Technology Officer	Direct	Sale	1,800	330.78	$595,404.00	2,860	4
2024-05-10	Hofmann, Thomas W	Director	-	Direct	Sale	617	365.92	$225,772.64	43,565	4
2024-05-07	Green, Eric Mark	Director,Officer	President, CEO and Board Chair	Direct	Sale	66,000	366.65	$24,198,900.00	152,908	4/A
2024-05-07	Green, Eric Mark	Director,Officer	President, CEO and Board Chair	Direct	Sale	66,000	366.65	$24,198,900.00	152,908	4
2024-03-11	Winters, Chad	Officer	VP, Chief Accounting Officer	Direct	Sale	815	358.82	$292,438.30	1,309	4
2024-02-28	Witherspoon, Charles	Officer	VP & Treasurer	Direct	Sale	2,019	358.62	$724,053.78	1,979	4
2024-02-27	Green, Eric Mark	Director,Officer	President, CEO and Board Chair	Direct	Sale	64,132	359.85	$23,077,900.20	152,908	4
2024-02-23	Abraham, Silji	Officer	SVP, Chief Technology Officer	Direct	Sale	7,012	365.00	$2,559,380.00	4,660	4
2023-12-04	Winters, Chad	Officer	VP, Chief Accounting Officer	Direct	Sale	1,013	349.00	$353,537.00	1,270	4/A
2023-12-01	Winters, Chad	Officer	VP, Chief Accounting Officer	Direct	Sale	1,013	349.00	$353,537.00	1,270	4
2023-10-31	Witherspoon, Charles	Officer	VP & Treasurer	Direct	Sale	1,190	322.38	$383,632.20	1,835	4
2023-08-30	Favorite, Annette F	Officer	Sr. VP & Chief HR Officer	Direct	Sale	2,000	414.56	$829,120.00	14,877	4
2023-08-22	Reiss-Clark, Cindy	Officer	Chief Commercial Officer	Direct	Sale	3,477	393.34	$1,367,643.18	4,320	4
2023-08-11	Lai, Quintin J	Officer	VP Strat & Investor Relations	Direct	Sale	21,101	395.43	$8,343,968.43	18,307	4
2023-08-09	Witherspoon, Charles	Officer	VP & Treasurer	Direct	Sale	1,680	396.54	$666,187.20	1,830	4
2023-08-08	Green, Eric Mark	Director,Officer	President & CEO	Direct	Sale	44,000	394.91	$17,376,040.00	140,574	4
2023-08-08	Abraham, Silji	Officer	SVP, Chief Technology Officer	Direct	Sale	8,160	397.44	$3,243,110.40	4,209	4
2023-08-02	Birkett, Bernard	Officer	Sr VP, Chief Fin & Ops Off	Direct	Sale	22,334	370.70	$8,279,213.80	4,366	4
2023-05-30	Witherspoon, Charles	Officer	VP & Treasurer	Direct	Sale	1,000	343.05	$343,050.00	1,830	4
2023-05-09	Green, Eric Mark	Director,Officer	President & CEO	Direct	Sale	44,000	363.81	$16,007,640.00	134,574	4
2023-05-01	Abraham, Silji	Officer	SVP, Chief Technology Officer	Direct	Sale	8,020	365.84	$2,934,036.80	4,209	4
2023-05-01	Hofmann, Thomas W	Director	-	Direct	Sale	1,212	365.58	$443,082.96	43,616	4
2023-05-01	Favorite, Annette F	Officer	Sr. VP & Chief HR Officer	Direct	Sale	13,012	366.46	$4,768,377.52	14,877	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

90.86%

Inst. Shares: 65,416,263

Shares Outstanding: 72,000,000

2025-12-31

91.32%

Inst. Shares: 66,023,256

Shares Outstanding: 72,300,000

2025-09-30

91.16%

Inst. Shares: 65,819,365

Shares Outstanding: 72,200,000

2025-06-30

92.55%

Inst. Shares: 66,818,931

Shares Outstanding: 72,200,000

2025-03-31

90.61%

Inst. Shares: 65,689,433

Shares Outstanding: 72,500,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	65,416,263	72,000,000	90.86%
2025-12-31	66,023,256	72,300,000	91.32%
2025-09-30	65,819,365	72,200,000	91.16%
2025-06-30	66,818,931	72,200,000	92.55%
2025-03-31	65,689,433	72,500,000	90.61%
2024-12-31	66,463,016	73,000,000	91.05%
2024-09-30	64,044,532	72,800,000	87.97%
2024-06-30	63,971,835	73,000,000	87.63%
2024-03-31	62,845,559	73,500,000	85.50%
2023-12-31	63,034,851	74,300,000	84.84%
2023-09-30	61,093,105	74,300,000	82.22%
2023-06-30	60,233,699	74,300,000	81.07%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

WEST PHARMACEUTICAL SERVICES INC (WST) — SEC Financial Statements & Analysis

WEST PHARMACEUTICAL SERVICES INC (WST) is a surgical & medical instruments & apparatus company, incorporated in PA. WEST PHARMACEUTICAL SERVICES INC trades on NYSE as: WST. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), WEST PHARMACEUTICAL SERVICES INC reported a 12.38% year-over-year revenue growth, a Gross Profit Margin of 36.79% (TTM), a Debt-to-Equity ratio of 0.36x, a Price-to-Sales (P/S) ratio of 7.64x (TTM), a Price-to-Book (P/B) ratio of 8.49x (TTM), at a market cap of $25.40B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 12.38%
Gross Profit Margin TTM: 36.79%
Debt To Equity: 0.36x
P/S TTM: 7.64x
P/B TTM: 8.49x
Market Cap: $25.40B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is WEST PHARMACEUTICAL SERVICES INC in?

WEST PHARMACEUTICAL SERVICES INC (WST) operates in the Surgical & Medical Instruments & Apparatus industry.

What is WST's market cap?

WEST PHARMACEUTICAL SERVICES INC (WST) has a market capitalization of $25.40B as of 2026-06-30.

What is WST's P/E ratio?

WEST PHARMACEUTICAL SERVICES INC (WST)'s trailing twelve month P/E ratio is 44.96x as of 2026-06-30.

What exchange does WST trade on?

WEST PHARMACEUTICAL SERVICES INC (WST) trades on the NYSE.

Where is WEST PHARMACEUTICAL SERVICES INC incorporated?

WEST PHARMACEUTICAL SERVICES INC is incorporated in PA.